Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2728 results

Sort By:

Symplicity China Study

Study ID: NCT07081243
Start Date: 2025-11-04
End Date: 2031-12-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment

Symplicity Spyral Renal Denervation System

Sponsor

Medtronic Vascular

Source: clinicaltrials.gov

Share:
Add to list

A Phase 2 Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma

Study ID: NCT07123090
Start Date: 2026-02
End Date: 2028-02-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

25

Intervention / Treatment

sasanlimab

Palbociclib

Axitinib

Sponsor

Stephanie Berg

Source: clinicaltrials.gov

Share:
Add to list

Aripiprazole in Body Focused Repetitive Behaviors

Study ID: NCT05545891
Start Date: 2026-06
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Placebo

Aripiprazole

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS

Study ID: NCT07138274
Start Date: 2026-04
End Date: 2031-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

90

Intervention / Treatment

Metyrapone 250 mg Oral Tablets

Placebo

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

The Effect of Gamification-Based Instructional Design Developed

Study ID: NCT07207590
Start Date: 2025-12-01
End Date: 2026-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

web-based gamification application

control group: traditional classroom learning techniques

Sponsor

Cukurova University

Source: clinicaltrials.gov

Share:
Add to list

A PRPCT to Assess the Efficacy & Safety of Chronic Pain Rehab Training Software for Alleviating Chronic Secondary Musculoskeletal Pain

Study ID: NCT06936059
Start Date: 2025-11-12
End Date: 2026-11-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Mixed Reality based analgesic therapy

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Lifestyle Intervention for Type 2 Diabetes in Primary Care (CREDOenAP)

Study ID: NCT07207980
Start Date: 2026-01-11
End Date: 2028-01-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

CREDOenAP intervention

Sponsor

Pere Virgili Health Park

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy

Study ID: NCT05896371
Start Date: 2028-03
End Date: 2034-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

500

Intervention / Treatment

177Lu-PSMA-I&T - escalating renal absorbed dose

177Lu-PSMA-I&T - recommended phase 2 regime

Sponsor

CHU of Quebec-Universite Laval

Source: clinicaltrials.gov

Share:
Add to list

Enhancing Wound Perfusion in High-Risk Lower Extremity Orthopaedic Surgery: A Study on Nitropaste Using Intraoperative SPY Imaging.

Study ID: NCT07004764
Start Date: 2025-12
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

15

Intervention / Treatment

Nitroglycerin Ointment 2%

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Study ID: NCT06391099
Start Date: 2026-01-10
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Best Practice

Biospecimen Collection

Computed Tomography

Dietary Intervention

Educational Activity

Glucose Measurement

Ketone Measurement

Administration Questionnaire

Sponsor

Ohio State University Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list